Announcements Trials
Browse Landscape

Phase

Phase 3 11Phase 2 9Phase 1 7Phase 4 6Phase NA 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 1

Interventions

LEO 43204 2methyl 5-aminolevulinate 1Photochemotherapy 1Gels 1Fluorouracil 1AVX001 15-aminolevulinic acid hexyl ester 13-ingenyl angelate 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Keratosis, Actinic × 3-ingenyl angelate × Clear all
NCT01803477 2025-02-24

Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm

LEO Pharma

Phase 1/2 Completed
37 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡